A study found that using antiviral tecovirimat (Tpoxx) within 7 days of mpox symptoms onset reduced disease progression in HIV-positive individuals. Of 112 participants, 56 received early tecovirimat, showing a 5.4% progression rate, compared to 26.8% in the …